Description
Developer of a non-invasive, electronic neuromodulation device intended to treat pathological diseases. The company's device is battery operated and self-administered that can safely and transcutaneously stimulate the occipital nerve for treating migraines, enabling patients to have a cost-effective option for immediate relief at the onset of a migraine.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 22-Apr-2016 | Completed | Startup | |||
2. Product Crowdfunding | 01-Jan-2014 | Cancelled | Startup | |||
1. Accelerator/Incubator | 01-Jan-2013 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Health Wildcatters | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |